PAK2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.682600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.650200E-01
Normal-vs-Stage2
6.609600E-01
Normal-vs-Stage3
1.784550E-01
Normal-vs-Stage4
8.258400E-01
Stage1-vs-Stage2
5.027200E-01
Stage1-vs-Stage3
3.449000E-01
Stage1-vs-Stage4
1.615760E-01
Stage2-vs-Stage3
1.947430E-01
Stage2-vs-Stage4
4.141800E-01
Stage3-vs-Stage4
1.153400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.384000E-01
Normal-vs-AfricanAmerican
8.891600E-01
Normal-vs-Asian
1.467950E-01
Caucasian-vs-AfricanAmerican
2.524000E-01
Caucasian-vs-Asian
3.540800E-01
AfricanAmerican-vs-Asian
2.301600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.339800E-01
Normal-vs-Female
4.648600E-01
Male-vs-Female
8.544800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.737600E-01
Normal-vs-Age(41-60Yrs)
9.867000E-01
Normal-vs-Age(61-80Yrs)
3.308600E-01
Normal-vs-Age(81-100Yrs)
3.150800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.637000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.296600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.821800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.002900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.607010E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.919800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.107400E-01
Normal-vs-Daily Drinker
1.321020E-01
Normal-vs-Weekly Drinker
2.353400E-01
Normal-vs-Occasional Drinker
8.623200E-01
Normal-vs-Social Drinker
6.528000E-01
Non Drinker-vs-Daily Drinker
6.157600E-01
Non Drinker-vs-Weekly Drinker
7.645200E-01
Non Drinker-vs-Occasional Drinker
1.002250E-01
Non Drinker-vs-Social Drinker
1.940760E-01
Daily Drinker-vs-Weekly Drinker
4.559600E-01
Daily Drinker-vs-Occasional Drinker
6.600200E-02
Daily Drinker-vs-Social Drinker
1.021950E-01
Weekly Drinker-vs-Occasional Drinker
1.392760E-01
Weekly Drinker-vs-Social Drinker
3.626200E-01
Occasional Drinker-vs-Social Drinker
3.689400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.660800E-01
Normal-vs-Grade 2
5.742000E-02
Normal-vs-Grade 3
2.320300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.105600E-02
Grade 1-vs-Grade 3
1.024200E-02
Grade 1-vs-Grade 4
2.660800E-01
Grade 2-vs-Grade 3
4.522400E-01
Grade 2-vs-Grade 4
5.742000E-02
Grade 3-vs-Grade 4
2.320300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.803800E-01
Normal-vs-NonDiabetic
5.355200E-01
Diabetic-vs-NonDiabetic
3.570600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.027000E-01
Normal-vs-NoPancreatitis
5.246200E-01
Pancreatitis-vs-NoPancreatitis
4.837600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.691400E-01
Normal-vs-N1
6.822800E-01
N0-vs-N1
1.859850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.492200E-01
Normal-vs-TP53-NonMutant
3.451600E-01
TP53-Mutant-vs-TP53-NonMutant
4.401700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
